The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow or peripheral blood stem cell transplantation

Bone Marrow Transplantation

Volumn 25, Issue 1, 2000, Pages 91-96

  Elmaagacli, A H ^a   Beelen, D W ^a   Trenschel, R ^a   Schaefer, U W ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

ALL; AML; BMT; MRD; PCR; wt 1

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; THIOTEPA;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 9; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MALE; MINIMAL RESIDUAL DISEASE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

EID: 0033964701     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702095     Document Type: Article

References (24)

1. Call KM, Glaser T, Ito CY et al. Isolation and characterization of a zine linger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990; 60: 509-520.
2. Haber Da, Sohn RL, Buckler AL et al. Alternative splicing and genomic structure of the Wilms' tumor gene wt1. Proc Natl Acad Sci USA 1991; 88: 9618-9622.
3. Rauscher FJ III, Morris JF, Tournay OE et al. Binding of the Wilms' tumor gene locus zinc finger protein to the EGR-1 consensus sequence. Science 1990; 250: 1259-1262.
4. Madden SL, Cook DM, Morris JF et al. Transcriptional repression mediated by the WT1 Wilms' tumor gene product. Science 1991; 253: 1550-1553.
5. Drummond IA, Madden SL, Rohwer P et al. Repression of the insulin-like growth factor gene by the Wilms' tumor suppressor wt1. Science 1992; 257: 674-677.
6. Harrington MA, Konicek B, Song A et al. Inhibition of colony-stimulating factor-1 promotor activity by the product of the Wilms' tumor locus. J Biol Chem 1993; 268: 21271-21276.
7. Dey BR, Sukhatme VP, Roberts AB et al. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor wt1 gene product. Mol Endocinol 1993; 8: 591-595.
8. Brieger J, Weidmann E, Fenchel K et al. The expression of the Wilm's tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Leukemia 1994; 8: 2136-2143.
9. Bergmann L, Miething C, Maurer U et al. High levels of Wilms' tumor gene (wt-1) mRNA in acute myeloid leukmias are associated with a worse long-term outcome. Blood 1997; 90: 1217-1225.
10. Schmid D, Heinze G, Linnerth B et al. Prognostic significance of wt-1 gene expression at diagnosis in adult de novo acute myeloid leukemia. Leukemia 1997; 11: 639-643.
11. Beelen DW, Quabeck K, Kaiser B et al. Six weeks of continuous intravenous cyclosporine and short course methotrexate as propyhlaxis for acute graft-versus-host disease after allogeneic hone marrow transplantation. Transplantation 1990; 50: 421-427.
12. Chomcvynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal Biochem 1987; 162: 156-159.
13. Inoue K, Sugiyama H, Ogawe H et al. Wt1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 1994; 84: 3071-3079.
14. Elmaagacli AH, Beelen DW, Kroll M et al. Detection of CBFB/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation. Bone Marrow Transplant 1998; 21: 159-166.
15. Elmaagacli AH, Beelen DW, Kroll M et al. Detection of AML1/ETO fusion transcripts in patients with t(8;21) acute myeloid leukemia after allogeneic bone marrow transplantation or peripheral blood progenitor cell transplantation. Blood 1997; 90: 3230-3231.
16. Repp R, Borkhardt A, Haupt E et al. Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis. Leukemia 1995; 9: 210-216.
17. Ikeda K, Sasaki K, Tasaka T et al. Reverse transcription-polymerase chain reaction for PML-RARα fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection. Leukemia 1993; 7: 544-548.
18. Maurer J, Janssen JWG, Thiel E et al. Detection of chimeric bcr-abl genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991; 337: 1055-1058.
19. Dveksler GS, Basile AA, Dieffenbach CW. Analysis of gene expression: use of oligonucleotide primers tor glyceraldehyde-3-phosphate dehydrogenase. PCR Methods and Applications. Cold Spring Harbor Laboratory: Cold Spring Harbor, 1992; 1: 283-284.
20. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-238.
21. Gluckberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
22. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. New Engl J Med 1975; 292: 895-902.
23. Inoue K, Ogawa H, Sonoda Y et al. Aberrant overexpression of the Wilms' tumor gene (wt-1) in human leukemia. Blood 1997; 89: 1405-1412.
24. Baird PN, Simmons PJ. Expression of the Wilms' tumor gene (wt1) in normal hemopoiesis. Exp Hematol 1997; 25: 312-320.